Clinical Trial Record

Return to Clinical Trials

Pancreatic Adenocarcinoma Gene Environment Risk Study


2004-01


2027-12


2027-12


10000

Study Overview

Pancreatic Adenocarcinoma Gene Environment Risk Study

After informed consent, participants will be asked to complete a medical/family history questionnaire and provide a blood sample. Some participants may also be asked to provide a urine sample. Individuals undergoing procedures that require collection of biological samples for clinical purposes may have these samples saved for research purposes. Participants will also be asked for their permission for study investigators to access medical records and/or recontact them for updates to their medical and family histories. Data and biospecimens will be stored for potential future research projects.

N/A

  • Pancreatic Cancer
    • STUDY19070256

    Study Record Dates

    These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

    Study Registration Dates Results Reporting Dates Study Record Updates

    2009-06-01  

    N/A  

    2024-10-10  

    2009-06-02  

    N/A  

    2024-10-15  

    2009-06-03  

    N/A  

    2024-10  

    Study Plan

    This section provides details of the study plan, including how the study is designed and what the study is measuring.

    Design Details

    Primary Purpose:
    N/A


    Allocation:
    N/A


    Interventional Model:
    N/A


    Masking:
    N/A


    Arms and Interventions

    Participant Group/ArmIntervention/Treatment
    : Pancreatic Cancer

    individuals who have been diagnosed with pancreatic cancer

    : Unaffected

    individuals who have not been diagnosed with pancreatic cancer

    Primary Outcome MeasuresMeasure DescriptionTime Frame
    The data will be used in cohort association studies. Endpoints will depend on the number of patients in the study and the number of markers that are being evaluated.10 years
    Secondary Outcome MeasuresMeasure DescriptionTime Frame

    Contacts and Locations

    This section provides the contact details for those conducting the study, and information on where this study is being conducted.

    Study Contact

    Name: Randall E Brand, MD

    Phone Number: 412-623-3105

    Email: brandre@upmc.edu

    Study Contact Backup

    Name: Beth Dudley, MS, MPH, CGC

    Phone Number: 412-623-3105

    Email: dudleyre@upmc.edu

    Participation Criteria

    Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

    Ages Eligible for Study:
    ALL

    Sexes Eligible for Study:
    18 Years

    Accepts Healthy Volunteers:
    1

      Inclusion Criteria:

    • Histologically confirmed or CT confirmed diagnosis of pancreatic adenocarcinoma
    • Subjects with abnormal imaging study (CT, MRI, MRCP, EUS)
    • Control subjects with a clinical diagnosis of a pancreas, liver, or intestinal condition
    • Control subject with acute pancreatitis
    • Control subject with chronic pancreatitis
    • Control subject with biliary obstruction
    • Control subject with pancreatic cyst
    • Member of a high risk family (≥ 1 close relative with pancreatic cancer)
    • Healthy control (without any of the above conditions)

    • Exclusion Criteria:

    • Under the age of 18 years
    • Unable to give informed consent
    • Inability to travel to Pittsburgh for in-person enrollment

    Collaborators and Investigators

    This is where you will find people and organizations involved with this study.


      • PRINCIPAL_INVESTIGATOR: Randall E Brand, MD, University of Pittsburgh

      Publications

      The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

      General Publications

      No publications available